Oxford Biomedica plc (OXBDF)

Oxford Biomedica Balance Sheet

Financials in millions GBP. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	60.65	103.72	141.29	108.94	46.74
Trading Asset Securities	-	-	-	0.07	0.24
Cash & Short-Term Investments	60.65	103.72	141.29	109.02	46.98
Cash Growth	-41.52%	-26.59%	29.60%	132.04%	147.77%
Accounts Receivable	41.33	13.34	45.01	35.95	47.33
Other Receivables	13.7	7.04	12.61	6.15	4.1
Receivables	55.03	20.39	57.62	42.1	51.42
Inventory	13.57	12.87	12.63	9.52	6.91
Prepaid Expenses	3.94	4.36	3.98	3.21	2.63
Total Current Assets	133.19	141.33	215.5	163.84	107.95
Property, Plant & Equipment	64.3	75.69	133.78	69.73	72.3
Goodwill	-	-	0.66	-	-
Other Intangible Assets	29.22	30.98	105.23	0.05	0.07
Long-Term Accounts Receivable	0.03	0.04	-	-	-
Other Long-Term Assets	4.9	4.3	5.01	3.61	3.61
Total Assets	231.64	252.34	460.18	237.23	183.93
Accounts Payable	9.61	6.05	13.6	5.26	7.78
Accrued Expenses	15.04	10.27	20.63	11.9	10.35
Current Portion of Long-Term Debt	0.28	-	-	-	-
Current Portion of Leases	4.14	3.65	3.3	0.85	4.48
Current Income Taxes Payable	1.51	1.48	2.35	1.9	1.59
Current Unearned Revenue	24.19	22.11	19.26	13.4	28.26
Other Current Liabilities	3.54	0.75	-	-	-
Total Current Liabilities	58.32	44.32	59.66	33.31	52.46
Long-Term Debt	39.79	38.53	39.78	-	-
Long-Term Leases	64.55	69.27	71.21	8.49	9.37
Long-Term Unearned Revenue	1.07	5.33	1.15	1.85	3.52
Long-Term Deferred Tax Liabilities	-	-	5.59	-	-
Other Long-Term Liabilities	7.42	17.06	46.61	6.24	5.84
Total Liabilities	171.16	174.51	223.99	49.89	71.18
Common Stock	52.98	48.4	48.13	43.09	41.16
Additional Paid-In Capital	394.86	380.33	379.95	307.77	258.02
Retained Earnings	-399.5	-352.92	-198.55	-165.81	-188.72
Comprehensive Income & Other	8.71	-1.81	-24.89	2.29	2.29
Total Common Equity	57.05	74.01	204.65	187.34	112.75
Minority Interest	3.44	3.83	31.54	-	-
Shareholders' Equity	60.49	77.83	236.19	187.34	112.75
Total Liabilities & Equity	231.64	252.34	460.18	237.23	183.93
Total Debt	108.76	111.46	114.28	9.34	13.85
Net Cash (Debt)	-48.11	-7.74	27	99.68	33.14
Net Cash Growth	-	-	-72.91%	200.80%	213.41%
Net Cash Per Share	-0.47	-0.08	0.28	1.16	0.41
Filing Date Shares Outstanding	105.96	96.8	96.26	86.18	82.32
Total Common Shares Outstanding	105.96	96.8	96.26	86.18	82.32
Working Capital	74.87	97.01	155.84	130.54	55.49
Book Value Per Share	0.54	0.76	2.13	2.17	1.37
Tangible Book Value	27.83	43.03	98.77	187.29	112.67
Tangible Book Value Per Share	0.26	0.44	1.03	2.17	1.37
Machinery	70.8	65.33	61.02	40.17	33.71
Leasehold Improvements	61.29	61.06	60.23	28.15	27.22
Order Backlog	150	94	94	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.